These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 398153)

  • 1. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mucolytic effects of acetylcysteine compared with bromhexine and a placebo in patients with chronic bronchitis].
    Heinig JH; Pedersen B; Andersen I; Dalgaard CE; Rasmussen O; Weeke ER; Enk B
    Ugeskr Laeger; 1985 Nov; 147(46):3694-7. PubMed ID: 3907080
    [No Abstract]   [Full Text] [Related]  

  • 3. Double blind crossover randomised study of bromhexine in chronic obstructive airway disease.
    Misra MP; Tiwari UC; Chaubal CC; Galhotra R
    J Assoc Physicians India; 1984 May; 32(5):423-5. PubMed ID: 6389491
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
    Aylward M; Maddock J; Dewland P
    Eur J Respir Dis Suppl; 1980; 111():81-9. PubMed ID: 7011835
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mucolytic acitivity of bromhexine guaiacol combination in chronic bronchopneumopathy patients].
    Clini V; Guadagni L; Zennaro M; Fumagalli G
    G Clin Med; 1979 Jun; 60(6):475-89. PubMed ID: 381086
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
    Kasielski M; Nowak D
    Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhaled N-acetylcysteine in combination with terbutaline.
    Stiksa G; Nemcek K; Melin S
    Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis.
    Armstrong ML
    Med J Aust; 1976 Apr; 1(17):612,614-5,617. PubMed ID: 778563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromhexine in severe asthma.
    Rudolf M; Riordan JF; Grant BJ; Maberly DJ; Saunders KB
    Br J Dis Chest; 1978 Oct; 72(4):307-12. PubMed ID: 365213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
    Brocard H; Charpin J; Germouty J
    Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
    Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
    Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian multicenter study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial.
    Valenti S; Marenco G
    Respiration; 1989; 56(1-2):11-5. PubMed ID: 2690235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromhexine for otitis media with effusion.
    Roydhouse N
    N Z Med J; 1981 Nov; 94(696):373-5. PubMed ID: 7033848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral N-acetylcysteine on mucus clearance.
    Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
    Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in immunoglobulins in the sputum and serum after the use of secretolytics in patients with chronic obstructive pulmonary disease].
    Prazić B; Acketa M; Obradović-Andelić S; Volf-Pavlović E
    Plucne Bolesti; 1985; 37(3-4):178-82. PubMed ID: 3836422
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial of the anti-plaque activity of a mucolytic agent, N-Acetyl Cysteine.
    Bowles WH; Goral V
    Dent Hyg (Chic); 1985 Oct; 59(10):454-6. PubMed ID: 3908155
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
    Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.